"Prof. Christopher Huber". Biontech Biography. Biontech. Retrieved 5 August 2021. "SEC Filing | BioNTech". investors.biontech.de. p. 130. Retrieved 28 December...

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...

at BioNTech's laboratories in Mainz, Germany, just days after the SARS-Cov-2 genetic sequence was first made public. In September 2020, BioNTech received...

Pfizer–BioNTech's BNT162b2 COVID-19 vaccine for widespread use. On 11 December, the FDA gave emergency use authorization for the Pfizer–BioNTech COVID-19...

Bank to address the health and economic impact of COVID-19. Meanwhile, BioNTech and the European Union are collaborating to assess mRNA vaccine production...

associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. In 2022, she left BioNTech to devote...

regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin...

delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine." By the end of September, Canada will receive the 40 million Pfizer-BioNTech doses. Major General Fortin...

On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional...

agreements with Fosun Pharma to each purchase 5 million doses of the Pfizer-BioNTech COVID-19 vaccine. Combined, the two deals would include a total of 10 million...